biomedicina slovenica


"HIV-1" : 130

  1. Pužar Dominkuš Pia; Ferdin Jana; Plemenitaš Ana; Peterlin Matija Boris; Peterlin Matija Boris; Lenassi Metka
    Nef is secreted in exosomes from Nef.GFP-expressing and HIV-1-infected human astrocytes
    2017
  2. Hladnik Anžej; Ferdin Jana; Goričar Katja; Deeks Steven G; Peterlin Matija Boris; Plemenitaš Ana; Dolžan Vita; Lenassi Metka
    Trans-activation response element RNA is detectable in the plasma of a subset of aviremic HIV-1-infected patients
    2017
  3. Ferdin Jana; Goričar Katja; Dolžan Vita; Plemenitaš Ana; Martin Jeffrey; Peterlin Matija Boris; Deeks Steven G; Lenassi Metka
    Nef-exosomes as putative biomarkers for inadequate treatment regimen of HIV-1 infected individuals
    2017
  4. Cunha Marcela Sabino; Lima Sampaio Thatiane; Peterlin Matija Boris; da Costa Luciana Jesus
    A truncated Nef peptide from SIVcpz inhibits the production of HIV-1 infectious progeny
    2016
  5. Magiorkinis Gkikas; Angelis Konstantinos; Mamais Ioannis; Katzourakis Aris; Hatzakis Angelos; Albert Jan; Lawyer Glenn; Hamouda Osamah; Struck Daniel; Poljak Mario
    The global spread of HIV-1 subtype B epidemic
    2016
  6. Hofstra L. Marije; Sauvageot Nicolas; Albert Jan; Alexiev Ivailo; Garcia Federico; Struck Daniel; van de Vijver David A. M. C.; Åsjö Birgitta; Beshkov Danail; Poljak Mario
    Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe
    2016
  7. Lunar Maja M.; Matković Ivana; Tomažič Janez; Vovko Tomaž; Pečavar Blaž; Poljak Mario
    Longitudinal trends of recent HIV-1 infections in Slovenia (1986-2012) determined using an incidence algorithm
    2015
  8. Ferdin Jana
    Zunajcelični vezikli kot potencialni biooznačevalci aktivnih rezervoarjev virusa HIV-1
    2016
  9. Stenovec Matjaž
    Znotrajcelična lokalizacija in mobilnost HIV-1 proteina Nef v humani mikrogliji v kulturi
    2016
  10. Lenassi Metka
    Zunajcelični vezikli
    2016
  11. Ferdin Jana; Goričar Katja; Dolžan Vita; Plemenitaš Ana; Deeks Steven G; Peterlin Matija Boris; Lenassi Metka
    Detection of Nef-exosomes in plasma of aviremic HIV-1 infected patients
    2016
  12. Fujs Komloš Kristina; Markocic P.; Kušar Blanka; Hošnjak Lea; Močilnik Tina; Poljak Mario
    Prospective evaluation of Cepheid Xpert HIV-1 Viral Load assay as a supplemental confirmatory HIV-1 test in the routine clinical laboratory setting
    2016
  13. Ramšak Andreja; Kristančič Lidija; Drinovec Borut; Ovčak-Deržič Stanka; Likar Miha
    Določanje serološke navzkrižne reaktivnosti med protitelesi na HIV-1 in antigeni HIV-2
    [Detection of serological cross-reactivity between HIV-1 and HIV-2]
    1993
  14. Darcis Gilles; Kula Anna; Bouchat Sophie; Fujinaga Koh; Corazza Francis; Ait-Ammar Amina; Delacourt Nadège; Melard Adeline; Kabeya Kabamba; Peterlin Matija Boris
    An in-depth comparison of latency-reversing agent combinations in various in vitro and ex vivo HIV-1 latency models identified bryostatin-1+JQ1 and ingenol-B+JQ1 to potently reactivate viral gene expression
    2015
  15. Rhee Soo-Yon; Jiménez Blanco José Luis; Jordan Michael R.; Taylor Jonathan; Lemey Philippe; Varghese Vici; Hamers Raph L.; Bertagnolio Silvia; de Wit Tobias F. Rinke; Aghokeng Avelin F.; Poljak Mario
    Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance
    2015
  16. Lunar Maja M.; Mlakar Jana; Abecasis Ana B; Vandamme Anne-Mieke; Tomažič Janez; Karner Primož; Vovko Tomaž; Pečavar Blaž; Volčanšek Gabriele; Poljak Mario
    Molekularna epidemiologija okužbe s HIV v Sloveniji
    [Molecular epidemiology of HIV infection in Slovenia]
    2014
  17. Frentz Dineke; van de Vijver David A. M. C.; Abecasis Ana B; Albert Jan; Hamouda Osamah; Jørgensen Louise; Kücherer Claudia; Struck Daniel; Schmit Jean-Claude; Vercauteren Jurgen; Poljak Mario
    Patterns of transmitted HIV drug resistance in Europe vary by risk group
    2014
  18. Pingen Marieke; Wensing Annemarie; Fransen Katrien; De Bel Annelies; de Jong Dorien; Hoepelman Andy IM; Magiorkinis Emmanouil; Paraskevis Dimitrios; Lunar Maja M.; Poljak Mario
    Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity
    2014
  19. Lunar Maja M.; Vandamme Anne-Mieke; Tomažič Janez; Karner Primož; Vovko Tomaž; Pečavar Blaž; Volčanšek Gabriele; Poljak Mario; Abecasis Ana B
    Bridging epidemiology with population genetics in a low incidence MSM-driven HIV-1 subtype B epidemic in Central Europe
    2015
  20. Angelis Konstantinos; Albert Jan; Mamais Ioannis; Magiorkinis Gkikas; Hatzakis Angelos; Hamouda Osamah; Stuck Daniel; Vercauteren Jurgen; Wensing Annemarie; Alexiev Ivailo; Poljak Mario
    Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE
    2015
  21. Mlakar Boštjan; Kocjan Boštjan; Hošnjak Lea; Fujs Komloš Kristina; Miloševič Miloš; Poljak Mario
    Betapapillomaviruses in the anal canal of HIV positive and HIV negative men who have sex with men
    2014
  22. José Diego Pandeló; Bartholomeeusen Koen; da Cunha Rodrigo Delvecchio; Monteiro Abreu Celina; Gliński Jan; Ferreira da Costa Thais Barbizan; Bacchi Rabay Ana Flávia Mello; Pianowski Filho Luiz Francisco; Dudycz Lech W.; Peterlin Matija Boris
    Reactivation of latent HIV-1 by new semi-synthetic ingeol esters
    2014
  23. Frentz Dineke; Wensing Annemarie; Albert Jan; Poljak Mario; Poljak Mario; Lunar Maja M.; Babič Janja; Tomažič Janez; Vidmar Ludvik; Vovko Tomaž D.; Karner Primož
    Limited cross-border infections in patients newly diagnosed with HIV in Europe
    2013
  24. Swenson Luke C.; Poljak Mario; Tomažič Janez
    Comparative performances of HIV-1 RNA load assays at low viral load levels
    2014
  25. Contreras Xavier; Mzoughi Olfa; Gaston Fabrice; Peterlin Matija Boris; Bahraoui Elmostafa
    Protein kinase C-delta regulates HIV-1 replication at an early post-entry step in macrophages
    2012
  26. Abecasis Ana B; Wensing Annemarie; Paraskevis Dimitrios; Poljak Mario; Stanojević Maja
    HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
    2013
  27. Grgić Ivana; Židovec-Lepej Snežana; Lunar Maja M; Poljak Mario; Vince Adriana; Baca-Vrakela Ivana; Planinic Ana; Seme Katja; Begovac Josip
    The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation
    2013
  28. Theys Kristof; Deforche Koen; Vercauteren Jurgen; Poljak Mario
    Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients
    2012
  29. Lunar Maja M; Zidovec-Lepej Snježana; Abecasis Ana B; Tomažič Janez; Vidmar Ludvik; Karner Primož; Vovko Tomaž D; Pečavar Blaž; Maver Polona J; Seme Katja; Poljak Mario
    Prevalence of HIV-1 transmitted drug resistance in Slovenia: 2005-2010
    2012
  30. Stanojevic Maja; Alexiev Ivailo; Beshkov Danail; Gokengin Deniz; Mezei Maria; Minarovits Janos; Otelea Dan; Paraschiv Simona; Poljak Mario; Židovec-Lepej Snježana; Paraskevis Dimitros
    HIV1 molecular epidemiology in the Balkans - a melting pot forhHigh genetic diversity
    2012
  31. Okeoma Chioma M; Low Audrey; Bailis Will; Fan Hung Y; Peterlin Matija B; Ross Susan R
    Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection
    2009
  32. Blazek Dalibor; Peterlin Matija B
    Tat-SIRT1 tango
    2008
  33. Barborič Matjaž; Yik Jasper HN; Czudnochowski Nadine; Yang Zhiyuan; Chen Ruichuan; Contreras Xavier; Geyer Matthias; Peterlin Matija B; Zhou Qiang
    Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription
    2007
  34. Contreras Xavier; Barborič Matjaž; Lenasi Tina; Peterlin Matija B
    HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription
    2007
  35. Okeoma Chioma M; Lovšin Nika; Peterlin Matija B; Ross Susan R
    APOBEC3 inhibits mouse mammary tumour virus replication in vivo
    2007
  36. Lenasi Tina; Peterlin BorisM; Barborič Matjaž
    Cap-binding protein complex links pre-mRNA capping to transcription elongation and alternative splicing through positive transcription elongation factor b (P-TEFb)
    2011
  37. Pegan K; Matkovič U; Miš K; Marš T; Pirkmajer S; Grubič Z
    siRNA silencing of HIV-1alpha annulates protecive effect of hypoxia against induced apoptosis of human myoblasts exposed to 1% oxygen under in vitro conditions
    2011
  38. Vandekerckhove LPR; Wensing AMJ; Kaiser R; Brun-Vezinet F; Clotet B; De Luca A; Dressler S; Garcia F; Geretti AM; Poljak Mario
    European guidelines on the clinical management of HIV-1 tropism testing
    2011
  39. Vandamme Anne-Mieke; Camacho Ricardo J; Ceccherini-Silberstein Francesca; De Luca Andrea; Palmisano Lucia; Paraskevis Dimitrios; Paredes Roger; Poljak Mario; Schmit Jean-Claude; Soriano Vincent; Walter Hauke; Soennerborg Anders
    European recommendations for the clinical use of HIV drug resistance testing: 2011 update
    2011
  40. Demetriou Victoria L; van de Vijver David AMC; Kousiappa Ioanna; Balotta Claudia; Clotet Nonaventura; Grossman Zehava; Jorgensen B; Lepej Z Snježana; Levy Itzchak; Poljak Mario
    Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in Europe
    2010
  41. van de Vijver DAMC; Wensing AMJ; Asjo B; Bruckova L; Bruun-Jorgensen L; Camacho R; Horban A; Linka M; Lazanas M; Poljak M
    HIV-1 drug-resistance patterns among patients on failing treatment in a large numver of European countries
    2010
  42. Ristić Smiljana; Starčević-Čiymarević Nada; Brajenović-Milić Bojana; Crnić-Martinović Marija; Kapović Miljenko
    Frequency of CCR5 gene 32-basepair deletion in Croatian normal population
    2005
  43. Seme K; Lunar MM; Tomažič J; Vidmar L; Karner P; Matičič M; Poljak M
    Low prevalence of hepatitis B and C infections among HIV-infected individuals in Slovenia: a nation-wide study, 1986-2008
    2009
  44. Lenassi Metka; Cagney Gerard; Liao Maofu; Vaupotič Tomaž; Bartholomeeusen Koen; Cheng Yifan; Krogan Nevan J; Plemenitaš Ana; Peterlin B Matija
    HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells
    2010
  45. Majerle Andreja; Manček-Keber Mateja; Pristovšek Primož; Jerala Roman
    Interaction of the HIV-1 V3 domain with bacterial lipopolysaccharide: a pattern recognition inhibition
    2009
  46. Vercauteren Jurgen; Wensing Annemarie M; Poljak Mario; Stanojević Maja
    Transmission of drug-resistant HIV-1 is stabilizing in Europe
    2009
  47. Mallal Simon; Phillips Elizabeth; Carosi Gianpiero; Molina Jean-Michel; Workman Cassy; Tomažič Janez; Jagel-Guedes Eva; Rugina Sorin; Kozyrev Oleg; Cid Juan Flores
    HLA-B*5701 screening for hypersensitivity to abacavir
    2008
  48. Seme K; Kotnik-Kevorkijan B; Baklan Z; Fujs K; Babič DZ; Poljak M
    False-positive result of a confirmatory human immunodeficiency virus line immuno assay in an apparently healthy individual - a case report
    2006
  49. Pirš Mateja; Poljak Mario; Seme Katja; Babič Dunja Z; Tomažič Janez
    Clinical features and virologic characteristics of primary and early HIV-1 infection in Slovenian patients
    2006
  50. Maver Polona J; Žmitek Andrej; Seme Katja; Poljak Mario
    Blood-stained letter received by HIV/AIDS reference laboratory in 1993-a historical case report
    2006
  51. Židovec-Lepej Snježana; Kosor Ela; Gagro Alenka; Vince Adriana; Remenar Anica; Poljak Mario
    Persistant immunodominant anti-gag SLYNTVATL responses in HIV-patients with up to 7 years of HAART
    2006
  52. Babič Dunja Z; Seme Katja; Tomažič Janez; Vidmar Ludvik; Poljak Mario
    HIV-1 subtype B epidemic and transmission patterns in Slovenia
    2006
  53. Babič Dunja
    Molecular identification of the Slovenian isolates of human immunodeficiency virus
    2006
  54. Babič Dunja Z; Poljak Mario; Seme Katja
    Mikrobiološka diagnostika okužbe s HIV
    2006
  55. Costa Luciana J; Chen Nan; Lopes Adriana; Aguiar Renato S; Tanuri Amilcar; Plemenitaš Ana; Peterlin B Matija
    Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1
    2006
  56. Babič DZ; Poljak M; Seme K; Tomažič J; Vidmar L
    Molecular epidemiology of HIV-1 subtypes based on analysis of pol sequences in Slovenia, 1996-2005
    2006
  57. Babič DZ; Poljak M; Zelnikar M; Seme K; Tomažič J; Vidmar L; Karner P
    Prevalence of antiretroviral drug resistance mutations in newly diagnosed HIV-1 patients in Slovenia in the period 2000-2004
    2005
  58. Babič Dunja Z; Poljak Mario; Seme Katja; Tomažič Janez; Vidmar Ludvik
    Molecular epidemiology of HIV-1 subtypes based on analysis of pol sequences in Slovenia, 1996-2005
    2006
  59. Babič Dunja Z; Zelnikar Mojca; Seme Katja; Vandamme Anne-Mieke; Snoeck Joke; Tomažič Janez; Vidmar Ludvik; Karner Primož; Poljak Mario
    Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naive patients in Slovenia, 2000-2004
    2006
  60. Babič DZ; Poljak M; Seme K; Tomažič J; Vidmar L
    Molecular epidemiology of HIV-1 subtypes based on analysis of pol sequences in Slovenia, 1996-2005
    2006
  61. Mezei Maria; Balog Katalin; Babič Dunja Z; Toth Gabor; Cech Gabor; Vajna Balazs; Tauber Tamas; Seme Katja; Tomažič Janez; Vidmar Ludvik; Poljak Mario; Minarovits Janos
    Genetic variability of gag and env regions of HIV type 1 strains circulating in Slovenia
    2006
  62. Poljak Mario; Kocjan Boštjan J; Seme Katja; Babič Dunja Z
    Real-time PCR for detection of parenterally transmissible viruses
    2005
  63. Babič Dunja Z; Poljak Mario; Seme Katja; Zelnikar Mojca; Tomažič Janez; Vidmar Ludvik; Karner Primož
    Prevalence of antiretroviral drug resistance mutations HIV-1 and non-B subtypes in newly diagnosed drug-naive patients in Slovenia, 2000 to 2004
    [Prevalenca mutacij, povezanih z odpornostjo virusa HIV-1 proti protiretrovirusnim zdravilom in ne-B podtipov pri nonoodkritih bolnikih v Sloveniji, 2000-2004]
    2005
  64. Poljak Mario; Seme Katja; Babič Dunja Z
    Molecular diagnostics of parenterally transmissible viruses
    [Molekularna diagnostika parenteralno prenosljivih virusov]
    2005
  65. Barborič Matjaž; Zhang Fan; Beseničar Mojca; Plemenitaš Ana; Peterlin B Matija
    Ubiquitylation of Cdk9 by Skp2 facilitates optimal tat transactivation
    2005
  66. Arnež Maja
    Novosti v pediatrični infektologiji
    [Novelties in pediatric infectology]
    2005
  67. Luft S; Seme K; Poljak M
    Laboratory diagnosis of human immunodeficiency virus infection
    2004
  68. Barborič Matjaž
    Vloga in uravnavanje P-TEFb pri elongaciji prepisovanja evkariotskih in virusnih genov
    [The function and regulation of P-TEFb in transcriptional elongation of eukaryotic and viral genes]
    2003
  69. Tomažič Janez
    HIV and AIDS
    2003
  70. Klavs Irena; Poljak Mario
    Unlinked anonymous monitoring of human immunodeficiency virus prevalence in high- and low-risk groups in Slovenia, 1993-2002
    2003
  71. Tanner-Racz Klara; Racz Paul
    The detection of the expression of viral RNAs in the course of HIV and SIV infection
    2003
  72. Zheng Yong-Hui; Plemenitaš Ana; Fielding Christopher J; Peterlin Matija B
    Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions
    2003
  73. Seme K; Poljak M; Begovac J; Vince A; Tomažič J; Vidmar L; Kniewald T
    Low prevalence of hepatitis C virus infection among human immunodeficiency virus type 1-infected individuals from Slovenia and Croatia
    2002
  74. Frank Mojca
    Ugotavljanje ogroženosti okuženih s HIV zaradi oportunističnih okužb z analizo limfocitnih populacij v krvi
    2002
  75. Matičič Mojca
    Prisotnost provirusne HIV-1 DNA in protiteles proti HIV-1 v gingivalni tekočini HIV-1 seropozitivnih oseb v Sloveniji
    1997
  76. Seme K; Poljak M; Marin IJ; Tomažič J; Vidmar L
    Hepatitis C virus infection in HIV-1 positive individuals from Slovenia
    2002
  77. Srovin Tina
    Razvoj nove diagnostične metode za hitro in zanesljivo ugotavljanje mutacije CCR5delta32
    2001
  78. Poljak M; Babič D; Seme K
    Retrospective evaluation of the Vidas HIV DUO test for simultaneous detection of anti-HIV antibody and p24 antigen
    2002
  79. Poljak M
    Određivanje rezistencije HIV-1 prema protuvirusnim lijekovima: nova virusološka metoda za praćenje tijeka liječenja HIV bolesnika
    2002
  80. Barborič Matjaž; Nissen Robert M; Kanazawa Satoshi; Jabrane-Ferrat Nabila; Peterlin Matija B
    NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II
    2001
  81. Banič S; Koren S; Tomažič J; Vidmar L; Ihan A; Poljak M; Avšič-Županc T
    Influenza vaccination of human immunodeficiency virus 1-infected patients receiving antiretroviral therapy
    2001
  82. Okamoto Hiroshi; Peterlin B Matija; Cujec Thomas P
    Mechanisms by which the HIV-encoded Tat protein increases the efficiency of transcriptional elongation by RNA polymerase II
    [Mehanizem HIV-kodiranega Tat proteina, s katerim poveča učinkovitost transkripcije z RNA polimerazo II]
    2000
  83. Stieler M; Dahler C; Pfeifer K; Witteler H; Kapprell HP; Rethwilm M; Heins G; Recchia O; Ekermo B; Levičnik-Stežinar S
    ABBOTT AxSYM HIV 1/2 gO - an assay for screening and diagnostic purposes with improved HIV-1 group 0 detectability
    2000
  84. Matičič Mojca; Poljak M; Tomažič J; Vidmar L; Kramar B; Skalerič U
    Gingival fluid (GF): possible role in transmission of HIV-1 in advanced HIV disease and advanced periodontal disease
    1998
  85. Tomažič Janez; Vidmar Ludvik; Karner Primož; Poljak Mario; Ihan Alojz; Levičnik-Stezinar Snežna; Klavs Irena
    2000 - HIV/aids v svetu in doma
    [2000 - HIV/aids world - wide and in Slovenia]
    2000
  86. Seme K; Poljak M; Marin IJ; Tomažič J; Vidmar L
    Hepatitis C virus infection in HIV-1 positive individuals from Slovenia
    2000
  87. Lukić L
    Safety of blood transfusion
    2000
  88. Poljak Mario; Seme Katja
    Parenteralno prenosljivi virusi v zobozdravstvu
    2000
  89. Matičič M; Poljak M; Kramar B; Tomažič J; Vidmar L; Zakotnik B; Skalerič U
    Proviral HIV-1 DNA in gingival crevicular fluid of HIV-1-infected patients in various stages of HIV disease
    2000
  90. Tomažič Janez; Vidmar Ludvik
    HIV-1 v nosečnosti in med porodom
    1998
  91. Stephens JC; Reich DE; Goldstein DB; Shin HD; Smith MW; Carrington M; Winkler C; Huttley GA; Allikmets R; Glavač D
    Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.
    1998
  92. Poljak Mario; Seme Katja; Marin Irena J; Tomažič Janez; Vidmar Ludvik; Matičič Mojca; Kasper Pia
    Seroprevalence of HIV-1 subtypes A-E among HIV-1 infected individuals from Slovenia
    2000
  93. Matičič M; Poljak M; Kramar B; Tomažič J; Vidmar L; Skalerič U
    Provirusna HIV-1 DNA v gingivalni tekočini bolnikov, okuženih z virusom HIV
    1998
  94. Hodošček Milan; Mavri Janez
    Irreversible inhibition of the HIV-1 protease: a QM/MM study
    1999
  95. Kramar Barbara
    Pogostnost bolezni ustne sluznice in obzobnih tkiv pri osebah v Sloveniji, okuženih s človeškim virusom imunske pomanjkljivosti (HIV-1) in virusom hepatitisa C (HCV)
    [Prevalence of oral pathology and periodontal disease in HIV-1 and HCV infected patients in Slovenia]
    1999
  96. Kramar B; Matičič M; Tomažič J; Vidmar L; Skalerič U
    Prevalence of oral candidiasis, hairy leukoplakia and periodontal disease in HIV-1 infected patients in Slovenia
    1998
  97. Židovec Snježana; Čulig Zdravka; Jeren Tatjana; Kardum Mirjana; Šifter Zoran; Begovac Josip; Vince Adrijana
    Imunofenotipizacija limfocita periferne krvi u sindromu mononukleoze
    1999
  98. Vidmar Ludvik; Trampuž Andrej
    Kožne spremembe pri bolnikih, okuženih s HIV
    [Skin manifestations in HIV infected patients]
    1999
  99. Poljak Mario; Marin Irena; Seme Katja; Tomažič Janez; Vidmar Ludvik
    Seroprevalence of major HIV-1 subtypes (A-E) among HIV-1 infected individuals from Slovenia
    1998
  100. Wahl Sharon M; Wild Teresa K; Sanneman Thomas C; Janoff Edward N
    Mucosal inhibitors of HIV-1
    [Sluznični zaviralci virusa imunske pomanjkljivosti pri človeku (HIV-1)]
    1998

1 101  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics